For HCPs Only
Recent Clinical Updates
Loading latest clinical updates
Medical Research

Biodegradable Sensors Cut Waste, Enhance Wearable Tech

Discover how sustainable wearable health sensors made from seafood waste can improve patient care and reduce environmental impact with biodegradable materials.

April 20, 2026
3 min read
Drug Update

Executive Brief

  • The News: Chitosan from seafood waste enables wearable sensors.
  • Clinical Win: 97% electrical performance retained after bending.
  • Target Specialty: Biomedical engineers developing wearable health monitors.

Key Data at a Glance

Material Source: Seafood waste (red claw shrimp, rock lobster, squid)

Material Used: Chitosan

Conducting Polymer: PEDOT:Tosylate

Prototype Retention: 97% of electrical performance after bending

Collaborating Institutions: QUT, University of South Australia, Nanyang Technological University (NTU)

Publication: Small Structures

Biodegradable Sensors Cut Waste, Enhance Wearable Tech

QUT researchers have created a prototype electronic device using a material made from seafood waste, paving the way for safe, flexible and sustainable wearable health sensors.

A team from the QUT Center for Materials Science has demonstrated that chitosan, a naturally derived, biodegradable biopolymer recovered from seafood waste such as red claw shrimp, rock lobster and squid, can be used with a high-performance conducting polymer film to create a new class of wearable electronic transistors.

The medical-grade polymer samples were supplied by Sunshine Coast-based industry partner Biomedical Chitosan.

The research, published in Small Structures, is a step toward the development of wearable biocompatible biosensors which could be able to monitor health in real-time without compromising comfort, safety or the environment.

Lead researcher Professor Prashant Sonar said the study was a significant step in building the next generation of wearable biomedical devices using a sustainable electronic approach.

"We have successfully shown that a film made from chitosan, a biopolymer derived from seafood waste, when coated with a conducting polymer, can act as the foundation for flexible transistors," Professor Sonar said.

"Not only do these devices work electrically, they are biocompatible, meaning they can safely interact with human cells, and they are mechanically strong enough to withstand bending and movement.

"That makes them ideal for future wearable health monitors."

Chitosan is already widely used in biomedical applications because it is non-toxic and biodegradable.

Using a process called vapor phase polymerization (VPP) in collaboration with the University of South Australia, the researchers coated thin with PEDOT:Tosylate film on chitosan, a material known for high conductivity.

The result was a bendable, skin-friendly electronic film that maintained high performance even when flexed hundreds of times.

QUT Ph.D. researcher Chattarika Khamhanglit, the study's first author, said the devices showed remarkable mechanical resilience and durability. "Our prototype retained up to 97% of its electrical performance after repeated bending tests.

"This gives us confidence these materials could be used in real-world applications such as health sensors that move with the body without losing accuracy."

The research was led by QUT but also involved key collaboration with Nanyang Technological University (NTU), Singapore, where researchers contributed expertise in organic transistors where the active PEDOT:Tos-coated devices conductance varies via electrolyte gating, which is needed for biological sensing.

The study also involved partners from the QUT Center for Biomedical Technologies and Central Analytical Research Facility.

Professor Sonar said biocompatible transistors could become the foundation for wearable biosensors that monitor vital signs or detect disease biomarkers. "Imagine a lightweight patch that can comfortably adhere to the skin and provide continuous, accurate health information to doctors or patients.

"This work shows that such devices can be made from safe, sustainable materials sourced from nature."

The next stage of the research will focus on integrating the chitosan-based devices into biosensing platforms for specific health applications, including non-invasive monitoring and point-of-care diagnostics.

Clinical Perspective — Dr. Rahul Verma, Oncology

Workflow: As I integrate wearable health sensors into my practice, I'm looking forward to using devices that can withstand bending and movement, making them ideal for patients with active lifestyles. With the prototype retaining up to 97% of its electrical performance after repeated bending tests, I'm confident in their durability. This could streamline my workflow by reducing device malfunctions and allowing for more accurate patient monitoring.

Economics: The article doesn't address cost directly, but the use of sustainable materials like chitosan from seafood waste could potentially reduce production costs in the long run. I'd expect the cost savings to be significant if these devices can be manufactured on a large scale, making them more accessible to patients. However, more research is needed to determine the exact economic impact of these wearable health sensors.

Patient Outcomes: The development of wearable biocompatible biosensors could greatly benefit my patients by allowing for real-time health monitoring without compromising comfort or safety. With the devices showing remarkable mechanical resilience and durability, I expect to see improved patient outcomes, particularly in cases where continuous monitoring is crucial. The fact that chitosan is non-toxic and biodegradable also reassures me that these devices can safely interact with human cells.

Transparency & Corrections

HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact [email protected].

Drug Update Briefing

Get weekly drug updates for Medical Research in your inbox.

Related Drug Updates